Dr. Manirasadat Hakimi

Dr. Manirasadat Hakimi, internist, specialist in kidney disease (nephrology)

Iran . Tehran

 

Education: General Medicine: Tehran University of Medical Sciences, Tehran. Iran

Residency of Internal Medicine: Tehran University of Medical Sciences, Tehran. Iran

 

 

 

 

 

Fellowship of Nephrology: Tehran University of Medical Sciences, Tehran. Iran

 

Academic degrees: Faculty of Tehran University of Medical Sciences

Research Activities

Publications:

 

1. 1. Hakemi M, Najafi I, Ganji MR, Khosravi. F, Nikbin. B. Peripheral blood microchimerism in female renal transplant recipients with male allografts. Transplant Proc 2001; 33: 2852-2853

 

2. 2. Hakemi M, Shahebrahimi K, Ganji MR, Najafi I, Broumand B. Side effects of Mycophenolate Mofetil (MMF) versus azathioprine in iranian renal transplant recipients (A single center experience). Transplant Proc 2002; 34:2091-2092

 

 

 

3. 3. Hakemi M, Ganji MR, Najafi I. Bone loss in the early period after renal transplantation. Transplant Proc 2003; 3: 2724

 

 

 

4. 4. Broumand B, Hakemi MS, Sabet MS. Impact of hepatitis C virus infection on short term outcomes in renal transplantation. Experimental and Clinical Transplantation 2004; 2:242-245

 

 

 

5. 5. Sabet S, Hakemi M, Najafi I, Ganji MR, Argani H, Broumand B. Impact of hepatitis C virus infection on short term outcome in renal transplantation: A single center study. Transplant Proc. 2003; 35, 2699-2700

 

 

 

6. 6. Kayedi M, Golbabaie M, Najafi I, Ganji MR, Naderi GH, Mehraban D, Hakemi M. Renal Transplantation in Iran: A Single Center Study. Transplant Proc 2001; 33(5): 1-2

 

 

 

7. 7. Golbabaie M, Kayedi M, Najafi I, Ganji MR, Naderi GH, Mehraban D, Hakemi MS. Chronic Renal Allograft Dysfunction: Immunologic and Nonimmunologic Risk Factors. Transplant Proc 2001 33(5):2691-2692

 

 

 

8. 8. Malakoutian T, Hakemi MS, Nassiri AA, Rambod M, Haghighi AN Broumand B, Fazel I. Socioeconomic status of Iranian living unrelated kidney donors: A multicenter study. Transplant Proc 2007; 39:824-825

 

 

 

9. 9. Ganji MR, Charkhchian M, Hakemi MS, Naderi GH, Solymanian T, Saddadi F, Amini M, Najafi I. Association of hyperglycemia on allograft function in the early period after renal transplantation. Transplant Proc 2007; 39: 852-854

 

 

 

10. Hakemi MS, Golbabaei M, Nassiri A, Kayedi M, Hosseini M, Atabak S, Ganji MR, Amini M, Saddadi F, Najafi I. Predictors of patient survival in CAPD: 10 years’ experience in two major CAPD centers in Tehran. IRAN. Iran J Kidney Dis 2010; 4(1): 44-9

 

 

 

11. 11. Nejatisafa AA, Mortaz-Hedjri S, Malakoutian T, Arbabi M, Hakemi MS, Haghighi AN, Mohammadi MR, Fazel I. Quality of Life and Life Events of Living Unrelated Kidney Donors in Iran: A Multicenter Study. Transplantation 2008; 86: 937-940

 

 

 

12. 12. Nassiri AA, Hakemi MS, Soulati M, Marashian M, Rahbar K, Azizi F. Effects of Heparin and Dalteparin on oxidative stress during hemodialysis in patients with ESRD. Iran J Kidney Dis 2009; 3(3): 162-167

 

 

 

13. 13. Najafi I, Hakemi MS, Safari S, Atabak S, Sanadgol H, Nouri-Majelan N, Ardalan MR, Moghadam AG, Ashegh H, Keshvari A. The story of continuous ambulatory peritoneal dialysis in Iran. Perit Dial Int 2010; 30(4): 430-3

 

14. 14. Saddadi F, Hakemi MS, Najafi I, Moghadam K, Ghavamzadeh A, Jahani M, Ganji MR, Amini M, Soleymanian T,Chronic kidney disease after hematopoietic cell transplantation: frequency, risk factors, and outcomes. Transplant Proc 2009; 41(7): 2895-7

 

 

 

15. 15. Saddadi F, Najafi I, Hakemi MS, Falaknazi K, Attari F, Bahar B. Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr. Shariati University Hospital in Tehran. Iran J Kidney Dis 2010; (4): 20-6

 

 

 

16. 16. Saddadi F, Attari F, Najafi I, Ganji MR, Hakemi MS, Amini M, Renal involvement in patients with hepatitis C virus infection. Iran J Kidney Dis 2010; 4(2): 123-7

 

17. 17. Nouri-Majelan N, Najafi I, Sanadgol H, Ganji MR, Atabak S, Hakemi MS, Soleymanian T. Description of an outbreak of acute sterile peritonitis in Iran. Perit Dial Int 2010; 30(1): 19-22

 

 

 

18- Nassiri AA, Hakemi MS, Asadzadeh R, Faizei AM, Alatab S, Miri R, Yaseri M. Differences in cardiovascular disease risk factors associated with maximum and mean carotid intima- media thickness among hemodialysis patients. Iran J Kidney Dis 2012 May; 6(3): 203-8

 

 

 

19-  M.Hakemi, I. Najafi, AA.Nassiri, S. alatab, F. Saddadi, T. Soleymanian, M.Amini, MR. Ganji, N. Nouri Majelan, M.Hosseini.  Association of over time urine volume and ultrafiltration changes with patient survival in CAPD. Renal Failure 2012, 34(10): 1223-1228

 

 

 

20- AA. Nassiri, M.Hakemi. Serum Magnesium Level and Cardiovascular Disease in Dialysis Patients.  Iran J Kidney Dis 2013; 7(1):2-4

 

 

 

21-AA. Nassiri, L.Lotfollahi, N. Behzadnia, I.Alavi Darazam, M. Hakemi, A. Rahimzadeh Kalaleh, M.  Kamalkhani. Blood Pressure Measurement and Left Ventricular Mass Index in Hemodialysis Patients: Comparison of Several Methods.  Iran J Kidney Dis 2018; 12(3):185-9

 

 

 

22- AA. Nassiri, M.Nafar,P. Ahmadpoor,M. Hakemi,Nasrollahi,H. Argani .

 

A Report of Utilization of Anti Thymocyte Globulin Among Renal Transplant Patients in Iran. Journal of Nephrology and Renal Transplantation 2018; 10(2): 4 –19.

 

 

 

23- Mohammad Reza Ganji, Zahra Shafii, Monir Sadat Hakemi, Vitamin D Supplementation and Risk of Hypercalciuria in Stone Formers, Iranian Journal of Kidney Diseases, Volume 13, Number 1, January 2019

 

 

 

24- Nasim Pirhadi Tavandashtia, Hossein Imani, Soraiya Ebrahimpour-Koujan, Shiva Samavat,                  Monir Sadat Hakemi, The effect of vitamin E supplementation on biomarkers of endothelial function and inflammation among hemodialysis patients: A double-blinded randomized clinical trial.Complement Ther Med. 2020 Mar;49:102357.

 

 

 

25-Samaneh Asgari, Seyyed Saeed Moazzeni, Fereidoun Azizi, Hengameh Abdi, Davood Khalili, Monir Sadat Hakemi and Farzad Hadaegh, Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study, Global Heart. 2020; 15(1): 29.

 

 

 

26- Amir Ahmad Nassiri, Monir Sadat Hakemi, Mir Mohammad Miri, Reza Shahrami, Azadeh Ahmadi Hoomleh, Tahereh Sabaghian, Blood purification with CytoSorb in critically ill COVID-19 patients: A case series of 26 patients, Artificial Organs 2021;001:1-10.

 

 

 

Abstracts

 

 

 

1. 1. Analysis of peritoneal equilibration test in diabetic and nondiabetic patients on CAPD,

 

Presented at the 9th congress of the International Society for Peritoneal Dialysis. June 2001.Montreal. Canada

 

2. 2. Acute Renal Failure Following Cardiac Surgery, presented in the 39 the congress of the EDTA, July 2002.Copenhagen. Denmark

 

3. 3. Evaluation of Peripheral and Central Nerve Integrity in Hemodialysis and Renal Transplantation, presented in the 39th congress of the EDTA, July 2002. Copenhagen. Denmark

 

 

 

4. 4. Seasonal Variation of Blood Pressure in Hemodialysis and Renal Transplant Patients, presented in the 39th congress of the EDTA, July 2002.Copenhagen. Denmark

 

 

 

5. 5. Bone Mass Densitometry in Renal Transplant Recipients, presented in the 8th international congress of the Middle East Society for Organ Transplantation. Masqaṭ. Oman. Oct 2002

 

 

 

6. 6. Evaluation of steroid response in patients with FSGS (A single center study in Iran), presented in the World Congress of Nephrology, 8-12 June, 2003. Berlin, Germany

 

 

 

7. 7. Renal outcome in Iranian families with ADPKD1&2 as detected by linkage analysis, presented in the World Congress of Nephrology, 8-12 June, 2003. Berlin, Germany

 

 

 

8. 8. A dynamic bone disease in CAPD patients, presented in the XLI congress of ERA-EDTA. 15-18 May, 2004.Lisbon, Portugal

 

 

 

9. 9. Intravenous ascorbic acid in comparison to intravenous iron in erythropoietin resistant anemia with iron overload in hemodialysis patients, presented in 3rd World Congress of Nephrology. 26-30 June 2005. Singapore

 

 

 

10. 10. Creatinine clearance, KT/V and peritoneal equilibration test results in continuous peritoneal dialysis patients, presented in the XLIV congress of the ERA-EDTA.21-24 June, 2007. Barcelona. Spain

 

 

 

11. Socioeconomic Status, Quality of Life and Life Events of Iranian Living Unrelated Kidney Donors, has been accepted and accepted as oral presentation in the “renal week 2008” (congress of American Society of Nephrology). Philadelphia, USA

 

 

 

12. 12. Iranian Living Unrelated Kidney Donors, Designation of Long-term Outcome Program: A Preliminary Report of 1 year follow up. Presented as a poster. MESOT 2008, Shiraz. Iran and accepted presentation

 

 

 

13. 13. Conversion to Sirolimus based immunosuppression in kidney transplant recipients: A single center study has been sent to MESOT 2008, Shiraz. Iran and accepted as poster presentation

 

 

 

14. 14. Designation of long-term outcome program for Iranian living unrelated kidney donors, presented in the ‘Renal week 2009’ (congress of American Society of Nephrology). San Diego. USA

 

 

 

15. 15. Different cardiovascular disease risk factors for the max and mean CIMT in hemodialysis patients accepted as poster presentation in EDTA 2011. Prague, Czech